-
1
-
-
68149089670
-
Synthesis and biological evaluation of imidazole thioacetanilides as novel non-nucleoside HIV-1 reverse transcriptase inhibitors
-
Zhan, P.; Liu, X.; Zhu, J.; Fang, Z.; Li, Z.; Pannecouque, C.; De Clercq, E. Synthesis and biological evaluation of imidazole thioacetanilides as novel non-nucleoside HIV-1 reverse transcriptase inhibitors. Bioorg. Med. Chem., 2009, 17, 5775-81.
-
(2009)
Bioorg. Med. Chem.
, vol.17
, pp. 5775-5781
-
-
Zhan, P.1
Liu, X.2
Zhu, J.3
Fang, Z.4
Li, Z.5
Pannecouque, C.6
De Clercq, E.7
-
2
-
-
84863290357
-
Design, Synthesis, and Biological Evaluation of 1-[(2-Benzyloxyl/alkoxyl) methyl]-5-halo-6-aryluracils as Potent HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with an Improved Drug Resistance Profile
-
Wang, X.; Zhang, J.; Huang, Y.; Wang, R.; Zhang, L.; Qiao, K.; Li, L.; Liu, C.; Ouyang, Y.; Xu, W.; Zhang, Z.; Shao, Y.; Jiang, S.; Ma, L.; Liu, J. Design, Synthesis, and Biological Evaluation of 1-[(2-Benzyloxyl/alkoxyl)methyl] -5-halo-6-aryluracils as Potent HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with an Improved Drug Resistance Profile. J. Med. Chem., 2012, 55, 2242-50.
-
(2012)
J. Med. Chem.
, vol.55
, pp. 2242-2250
-
-
Wang, X.1
Zhang, J.2
Huang, Y.3
Wang, R.4
Zhang, L.5
Qiao, K.6
Li, L.7
Liu, C.8
Ouyang, Y.9
Xu, W.10
Zhang, Z.11
Shao, Y.12
Jiang, S.13
Ma, L.14
Liu, J.15
-
3
-
-
84860289205
-
Strategies for the Design of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: Lessons from the Development of Seven Representative Paradigms
-
Li, D.; Zhan, P.; De Clercq, E.; Liu, X. Strategies for the Design of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: Lessons from the Development of Seven Representative Paradigms. J. Med. Chem, 2012, 55, 3595-613.
-
(2012)
J. Med. Chem
, vol.55
, pp. 3595-3613
-
-
Li, D.1
Zhan, P.2
De Clercq, E.3
Liu, X.4
-
4
-
-
79955104761
-
Novel HIV-1 non-nucleoside reverse transcriptase inhibitors: A patent review (2005 - 2010)
-
Zhan, P.; Liu, X. Novel HIV-1 non-nucleoside reverse transcriptase inhibitors: a patent review (2005 - 2010). Expert Opin. Ther. Pat., 2011, 21, 717-96.
-
(2011)
Expert Opin. Ther. Pat.
, vol.21
, pp. 717-796
-
-
Zhan, P.1
Liu, X.2
-
5
-
-
68649109125
-
1,2,3-Selenadiazole thioacetanilides: Synthesis and anti-HIV activity evaluation
-
Zhan, P.; Liu, X.; Fang, Z.; Pannecouque, C.; De Clercq, E. 1,2,3-Selenadiazole thioacetanilides: synthesis and anti-HIV activity evaluation. Bioorg Med Chem, 2009, 17, 6374-9.
-
(2009)
Bioorg Med Chem
, vol.17
, pp. 6374-6379
-
-
Zhan, P.1
Liu, X.2
Fang, Z.3
Pannecouque, C.4
De Clercq, E.5
-
6
-
-
80053197763
-
Arylazolylthioacetanilide. Part 8: Design, synthesis and biological evaluation of novel 2-(2-(2,4-dichlorophenyl)-2H-1,2,4-triazol-3-ylthio)-N- arylacetamides as potent HIV-1 inhibitors
-
Zhan, P.; Chen, X.; Li, X.; Li, D.; Tian, Y.; Chen, W.; Pannecouque, C.; De Clercq, E.; Liu, X. Arylazolylthioacetanilide. Part 8: Design, synthesis and biological evaluation of novel 2-(2-(2,4-dichlorophenyl)-2H-1,2,4-triazol-3- ylthio)-N-arylacetamides as potent HIV-1 inhibitors. Eur. J. Med. Chem., 2011, 46, 5039-45.
-
(2011)
Eur. J. Med. Chem.
, vol.46
, pp. 5039-5045
-
-
Zhan, P.1
Chen, X.2
Li, X.3
Li, D.4
Tian, Y.5
Chen, W.6
Pannecouque, C.7
De Clercq, E.8
Liu, X.9
-
7
-
-
77950639336
-
TSG101: A novel anti-HIV-1 drug target
-
Chen, H.; Liu, X.; Li, Z.; Zhan, P.; De Clercq, E. TSG101: A novel anti-HIV-1 drug target. Curr. Med. Chem., 2010, 17, 750-8.
-
(2010)
Curr. Med. Chem.
, vol.17
, pp. 750-758
-
-
Chen, H.1
Liu, X.2
Li, Z.3
Zhan, P.4
De Clercq, E.5
-
8
-
-
80053197763
-
Arylazolylthioacetanilide. Part 8: Design, synthesis and biological evaluation of Novel 2-(2-(2, 4-Dichlorophenyl)-2H-1, 2, 4-triazol-3-ylthio)-N- arylacetamides As Potent HIV-1 inhibitors
-
Zhan, P.; Chen, X.; Li, X.; Li, D.; Tian, Y.; Chen, W.; Pannecouque, C.; De Clercq, E.; Liu, X. Arylazolylthioacetanilide. Part 8: Design, synthesis and biological evaluation of Novel 2-(2-(2, 4-Dichlorophenyl)-2H-1, 2, 4-triazol-3-ylthio)-N-arylacetamides As Potent HIV-1 inhibitors. Eur. J. Med. Chem., 2011, 46, 5039-45.
-
(2011)
Eur. J. Med. Chem.
, vol.46
, pp. 5039-5045
-
-
Zhan, P.1
Chen, X.2
Li, X.3
Li, D.4
Tian, Y.5
Chen, W.6
Pannecouque, C.7
De Clercq, E.8
Liu, X.9
-
9
-
-
77956478098
-
Synthesis and anti-HIV activity evaluation of novel N'-arylidene-2-[1- (naphthalen-1-yl)-1H-tetrazol-5-ylthio] acetohydrazides
-
Zhan, P.; Liu, H.; Liu, X.; Wang, Y.; Pannecouque, C.; Witvrouw, M.; De Clercq, E. Synthesis and anti-HIV activity evaluation of novel N'-arylidene-2-[1-(naphthalen-1-yl)-1H-tetrazol-5-ylthio] acetohydrazides. Med. Chem. Res., 2010, 19, 652-63.
-
(2010)
Med. Chem. Res.
, vol.19
, pp. 652-663
-
-
Zhan, P.1
Liu, H.2
Liu, X.3
Wang, Y.4
Pannecouque, C.5
Witvrouw, M.6
De Clercq, E.7
-
10
-
-
53349162138
-
1, 2, 3-Thiadiazole thioacetanilides as a novel class of potent HIV-1 non-nucleoside reverse transcriptase inhibitors
-
Zhan, P.; Liu, X.; Cao, Y.; Wang, Y.; Pannecouque, C.; De Clercq, E. 1, 2, 3-Thiadiazole thioacetanilides as a novel class of potent HIV-1 non-nucleoside reverse transcriptase inhibitors. Bioorg. Med. Chem. Lett., 2008, 18, 5368-71.
-
(2008)
Bioorg. Med. Chem. Lett.
, vol.18
, pp. 5368-5371
-
-
Zhan, P.1
Liu, X.2
Cao, Y.3
Wang, Y.4
Pannecouque, C.5
De Clercq, E.6
-
11
-
-
70349774254
-
Synthesis and anti-HIV activity evaluation of 2-(4-(naphthalen-2-yl)-1, 2, 3-thiadiazol-5-ylthio)-N-acetamides as novel nonnucleoside HIV-1 reverse transcriptase inhibitors
-
Zhan, P.; Liu, X.; Fang, Z.; Li, Z.; Pannecouque, C.; De Clercq, E. Synthesis and anti-HIV activity evaluation of 2-(4-(naphthalen-2-yl)-1, 2, 3-thiadiazol-5-ylthio)-N-acetamides as novel nonnucleoside HIV-1 reverse transcriptase inhibitors. Eur. J. Med. Chem., 2009, 44, 4648-53.
-
(2009)
Eur. J. Med. Chem.
, vol.44
, pp. 4648-4653
-
-
Zhan, P.1
Liu, X.2
Fang, Z.3
Li, Z.4
Pannecouque, C.5
De Clercq, E.6
-
12
-
-
68649109125
-
1, 2, 3-Selenadiazole thioacetanilides: Synthesis and anti-HIV activity evaluation
-
Zhan, P.; Liu, X.; Fang, Z.; Pannecouque, C.; De Clercq, E. 1, 2, 3-Selenadiazole thioacetanilides: Synthesis and anti-HIV activity evaluation. Bioorg. Med. Chem., 2009, 17, 6374-9.
-
(2009)
Bioorg. Med. Chem.
, vol.17
, pp. 6374-6379
-
-
Zhan, P.1
Liu, X.2
Fang, Z.3
Pannecouque, C.4
De Clercq, E.5
-
13
-
-
68149145657
-
Novel 1, 2, 3-thiadiazole derivatives as HIV-1 NNRTIs with improved potency: Synthesis and preliminary SAR studies
-
Zhan, P.; Liu, X.; Li, Z.; Fang, Z.; Wang, D.; Pannecouque, C.; De Clercq, E. Novel 1, 2, 3-thiadiazole derivatives as HIV-1 NNRTIs with improved potency: synthesis and preliminary SAR studies. Bioorg. Med. Chem., 2009, 17, 5920-7.
-
(2009)
Bioorg. Med. Chem.
, vol.17
, pp. 5920-5927
-
-
Zhan, P.1
Liu, X.2
Li, Z.3
Fang, Z.4
Wang, D.5
Pannecouque, C.6
De Clercq, E.7
-
14
-
-
68149089670
-
Synthesis and biological evaluation of imidazole thioacetanilides as novel non-nucleoside HIV-1 reverse transcriptase inhibitors
-
Zhan, P.; Liu, X.; Zhu, J.; Fang, Z.; Li, Z.; Pannecouque, C.; De Clercq, E. Synthesis and biological evaluation of imidazole thioacetanilides as novel non-nucleoside HIV-1 reverse transcriptase inhibitors. Bioorg. Med. Chem., 2009, 17, 5775-81.
-
(2009)
Bioorg. Med. Chem.
, vol.17
, pp. 5775-5781
-
-
Zhan, P.1
Liu, X.2
Zhu, J.3
Fang, Z.4
Li, Z.5
Pannecouque, C.6
De Clercq, E.7
-
15
-
-
77954695191
-
1, 2, 3Thiadiazole Thioacetanilides. Part 2: Synthesis and biological evaluation of a new series of 2-{[4-(3,4-dichlorophenyl)-1,2,3-thiadiazol-5-yl] sulfanyl}acetanilides as HIV-1 inhibitors
-
Zhan, P.; Liu, X.Y.; Li, Z.Y.; Fang, Z.J.; Pannecouque, C.; De Clercq, E. 1, 2, 3Thiadiazole Thioacetanilides. Part 2: Synthesis and biological evaluation of a new series of 2-{[4-(3,4-dichlorophenyl)-1,2,3-thiadiazol-5-yl] sulfanyl}acetanilides as HIV-1 inhibitors. Chem. Biodivers, 2010, 7, 1717-27.
-
(2010)
Chem. Biodivers
, vol.7
, pp. 1717-1727
-
-
Zhan, P.1
Liu, X.Y.2
Li, Z.Y.3
Fang, Z.J.4
Pannecouque, C.5
De Clercq, E.6
-
16
-
-
84875412177
-
Synthesis and anti-HIV evaluation of novel 1,2,4-triazole derivatives as potential non-nucleoside HIV-1 reverse transcriptase inhibitors
-
Li, Z.; Cao, Y.; Zhan, P.; Pannecouque, C.; Balzarini, J.; De Clercq, E.; Liu, X. Synthesis and anti-HIV evaluation of novel 1,2,4-triazole derivatives as potential non-nucleoside HIV-1 reverse transcriptase inhibitors. Lett. Drug Des. Discov., 2012, 10, 27-34.
-
(2012)
Lett. Drug Des. Discov.
, vol.10
, pp. 27-34
-
-
Li, Z.1
Cao, Y.2
Zhan, P.3
Pannecouque, C.4
Balzarini, J.5
De Clercq, E.6
Liu, X.7
-
17
-
-
76149120388
-
AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading
-
Trott, O.; Olson, A.J. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem., 2010, 31, 455-61.
-
(2010)
J. Comput. Chem.
, vol.31
, pp. 455-461
-
-
Trott, O.1
Olson, A.J.2
-
18
-
-
68149109726
-
Sulfanyltriazole/tetrazoles: A promising class of HIV-1 NNRTIs
-
Zhan, P.; Li, Z.; Liu, X.; De Clercq, E. Sulfanyltriazole/tetrazoles: a promising class of HIV-1 NNRTIs. Mini. Rev. Med. Chem., 2009, 9, 1014-23.
-
(2009)
Mini. Rev. Med. Chem.
, vol.9
, pp. 1014-1023
-
-
Zhan, P.1
Li, Z.2
Liu, X.3
De Clercq, E.4
-
19
-
-
33746478032
-
The chemistry of mercapto-and thione-substituted 1, 2, 4-triazoles and their utility in heterocyclic synthesis
-
Shaker, R.M. The chemistry of mercapto-and thione-substituted 1, 2, 4-triazoles and their utility in heterocyclic synthesis. Arkivoc, 2006, 9, 59-112.
-
(2006)
Arkivoc
, vol.9
, pp. 59-112
-
-
Shaker, R.M.1
-
20
-
-
68149145657
-
Novel 1,2,3-thiadiazole derivatives as HIV-1 NNRTIs with improved potency: Synthesis and preliminary SAR studies
-
Zhan, P.; Liu, X.; Li, Z.; Fang, Z.; Wang, D.; Pannecouque, C.; De Clercq, E. Novel 1,2,3-thiadiazole derivatives as HIV-1 NNRTIs with improved potency: Synthesis and preliminary SAR studies. Bioorg. Med. Chem., 2009, 17, 5920-7.
-
(2009)
Bioorg. Med. Chem.
, vol.17
, pp. 5920-5927
-
-
Zhan, P.1
Liu, X.2
Li, Z.3
Fang, Z.4
Wang, D.5
Pannecouque, C.6
De Clercq, E.7
|